Literature DB >> 26301814

Selective Treg reconstitution during lymphopenia normalizes DC costimulation and prevents graft-versus-host disease.

Holly A Bolton, Erhua Zhu, Alexandra M Terry, Thomas V Guy, Woon-Puay Koh, Sioh-Yang Tan, Carl A Power, Patrick Bertolino, Katharina Lahl, Tim Sparwasser, Elena Shklovskaya, Barbara Fazekas de St Groth.   

Abstract

Regulatory T cells (Tregs) have been shown to enhance immune reconstitution and prevent graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation; however, it is unclear how Tregs mediate these effects. Here, we developed a model to examine the mechanism of Treg-dependent regulation of immune reconstitution. Lymphopenic mice were selectively reconstituted with Tregs prior to transfer of conventional CD4+ T cells. Full Treg reconstitution prevented the rapid oligoclonal proliferation that gives rise to pathogenic CD4 effector T cells, while preserving the slow homeostatic form of lymphopenia-induced peripheral expansion that repopulates a diverse peripheral T cell pool. Treg-mediated CTLA-4-dependent downregulation of CD80/CD86 on DCs was critical for inhibition of rapid proliferation and was a function of the Treg/DC ratio achieved by reconstitution. In an allogeneic BM transplant model, selective Treg reconstitution before T cell transfer also normalized DC costimulation and provided complete protection against GVHD. In contrast, cotransfer of Tregs was not protective. Our results indicate that achieving optimal recovery from lymphopenia should aim to improve early Treg reconstitution in order to increase the relative number of Tregs to DCs and thereby inhibit spontaneous oligoclonal T cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26301814      PMCID: PMC4588278          DOI: 10.1172/JCI76031

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  67 in total

Review 1.  Carboxyfluorescein diacetate succinimidyl ester and the virgin lymphocyte: a marriage made in heaven.

Authors:  B Fazekas de St Groth; A L Smith; W P Koh; L Girgis; M C Cook; P Bertolino
Journal:  Immunol Cell Biol       Date:  1999-12       Impact factor: 5.126

2.  CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells.

Authors:  L Cederbom; H Hall; F Ivars
Journal:  Eur J Immunol       Date:  2000-06       Impact factor: 5.532

3.  A closer look at homeostatic proliferation of CD4+ T cells: costimulatory requirements and role in memory formation.

Authors:  H Gudmundsdottir; L A Turka
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

4.  Both exogenous commensal and endogenous self antigens stimulate T cell proliferation under lymphopenic conditions.

Authors:  Jeong-su Do; Gilles Foucras; Nobuhiko Kamada; Austin F Schenk; Michael Shaw; Gabriel Nuñez; William E Paul; Booki Min
Journal:  Cell Immunol       Date:  2011-11-25       Impact factor: 4.868

5.  Recent immune status determines the source of antigens that drive homeostatic T cell expansion.

Authors:  William C Kieper; Amy Troy; J Theodore Burghardt; Chris Ramsey; Joon Youb Lee; Han-Qing Jiang; Wolfgang Dummer; Hao Shen; John J Cebra; Charles D Surh
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

Review 6.  T cell homeostasis: keeping useful T cells alive and live T cells useful.

Authors:  Stephen C Jameson
Journal:  Semin Immunol       Date:  2005-06       Impact factor: 11.130

7.  Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.

Authors:  O Alpdogan; C Schmaltz; S J Muriglan; B J Kappel; M A Perales; J A Rotolo; J A Halm; B E Rich; M R van den Brink
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

8.  Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous.

Authors:  M F Bachmann; G Köhler; B Ecabert; T W Mak; M Kopf
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

9.  Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses.

Authors:  Sofia R Gameiro; Jorge A Caballero; Jack P Higgins; David Apelian; James W Hodge
Journal:  Cancer Immunol Immunother       Date:  2011-05-05       Impact factor: 6.968

Review 10.  Immune reconstitution after hematopoietic cell transplantation.

Authors:  Mark Bosch; Faisal M Khan; Jan Storek
Journal:  Curr Opin Hematol       Date:  2012-07       Impact factor: 3.284

View more
  35 in total

Review 1.  Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation?

Authors:  F Lussana; M Di Ianni; A Rambaldi
Journal:  Bone Marrow Transplant       Date:  2017-03-20       Impact factor: 5.483

2.  Unregulated antigen-presenting cell activation by T cells breaks self tolerance.

Authors:  Jaeu Yi; Jisun Jung; Sung-Wook Hong; Jun Young Lee; Daehee Han; Kwang Soon Kim; Jonathan Sprent; Charles D Surh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-31       Impact factor: 11.205

3.  Lower incidence of acute GVHD is associated with the rapid recovery of CD4+CD25+CD45RA+ regulatory T cells in patients who received haploidentical allografts from NIMA-mismatched donors: A retrospective (development) and prospective (validation) cohort-based study.

Authors:  Yu Wang; Xiang-Yu Zhao; Lan-Ping Xu; Xiao-Hui Zhang; Wei Han; Huan Chen; Feng-Rong Wang; Xiao-Dong Mo; Yuan-Yuan Zhang; Xiao-Su Zhao; Kong Y; Kai-Yan Liua; Xiao-Jun Huang; Xue-Zhong Yu; Ying-Jun Chang
Journal:  Oncoimmunology       Date:  2016-10-14       Impact factor: 8.110

Review 4.  Chemotherapy and immunotherapy: A close interplay to fight cancer?

Authors:  Aurélie Hanoteau; Muriel Moser
Journal:  Oncoimmunology       Date:  2016-06-21       Impact factor: 8.110

5.  Regulatory T Cells Maintain Selective Access to IL-2 and Immune Homeostasis despite Substantially Reduced CD25 Function.

Authors:  Erika T Hayes; Cassidy E Hagan; Liliane Khoryati; Marc A Gavin; Daniel J Campbell
Journal:  J Immunol       Date:  2020-10-14       Impact factor: 5.422

6.  A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.

Authors:  Marco Cardone; Karla Garcia; Mulualem E Tilahun; Lisa F Boyd; Sintayehu Gebreyohannes; Masahide Yano; Gregory Roderiquez; Adovi D Akue; Leslie Juengst; Elliot Mattson; Suryatheja Ananthula; Kannan Natarajan; Montserrat Puig; David H Margulies; Michael A Norcross
Journal:  J Clin Invest       Date:  2018-05-21       Impact factor: 14.808

Review 7.  Immunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells.

Authors:  Jessica Bourque; Daniel Hawiger
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 8.  Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells.

Authors:  Nicholas A Zwang; Joseph R Leventhal
Journal:  J Am Soc Nephrol       Date:  2017-05-02       Impact factor: 10.121

Review 9.  EZH2 as a mediator of treatment resistance in melanoma.

Authors:  Jessamy C Tiffen; Stuart J Gallagher; Hsin-Yi Tseng; Fabian V Filipp; Barbara Fazekas de St. Groth; Peter Hersey
Journal:  Pigment Cell Melanoma Res       Date:  2016-05-25       Impact factor: 4.693

10.  Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD.

Authors:  Ana C Alho; Haesook T Kim; Marie J Chammas; Carol G Reynolds; Tiago R Matos; Edouard Forcade; Jennifer Whangbo; Sarah Nikiforow; Corey S Cutler; John Koreth; Vincent T Ho; Philippe Armand; Joseph H Antin; Edwin P Alyea; Joao F Lacerda; Robert J Soiffer; Jerome Ritz
Journal:  Blood       Date:  2015-12-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.